pX601-GFP Citations (4)
Originally described in: Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and beta-thalassemia.Ye L, Wang J, Tan Y, Beyer AI, Xie F, Muench MO, Kan YW Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10661-5. doi: 10.1073/pnas.1612075113. Epub 2016 Sep 6. PubMed Journal
Articles Citing pX601-GFP
| Articles |
|---|
Targeted Transgene Activation in the Brain Tissue by Systemic Delivery of Engineered AAV1 Expressing CRISPRa.
Lau CH, Ho JW, Lo PK, Tin C.
Mol Ther Nucleic Acids. 2019 Jun 7;16:637-649. doi: 10.1016/j.omtn.2019.04.015. Epub 2019 Apr 23.
PubMed
Associated Plasmids |
| ADT-OH, a hydrogen sulfide-releasing donor, induces apoptosis and inhibits the development of melanoma in vivo by upregulating FADD. Cai F, Xu H, Cao N, Zhang X, Liu J, Lu Y, Chen J, Yang Y, Cheng J, Hua ZC, Zhuang H. Cell Death Dis. 2020 Jan 16;11(1):33. doi: 10.1038/s41419-020-2222-9. PubMed |
Optimization of S. aureus dCas9 and CRISPRi Elements for a Single Adeno-Associated Virus that Targets an Endogenous Gene.
Backstrom JR, Sheng J, Wang MC, Bernardo-Colon A, Rex TS.
Mol Ther Methods Clin Dev. 2020 Sep 6;19:139-148. doi: 10.1016/j.omtm.2020.09.001. eCollection 2020 Dec 11.
PubMed
Associated Plasmids |
| Adeno-Associated Vector-Delivered CRISPR/SaCas9 System Reduces Feline Leukemia Virus Production In Vitro. Helfer-Hungerbuehler AK, Shah J, Meili T, Boenzli E, Li P, Hofmann-Lehmann R. Viruses. 2021 Aug 18;13(8). pii: v13081636. doi: 10.3390/v13081636. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.